BenQ's dialysis overseas arrangement and one-stop strategy have worked well. In 2021, it has achieved outstanding results. The revenue of dialysis business has increased by nearly 80% compared with the same period last year, hitting a new high since the company was established in 2014.
The BenQ Qflux Dialyzer produced by BenQ Dialysis Technology, a subsidiary of Qisda, continues to expand its overseas market territory. In October 2011, it officially obtained the medical devices license issued by the Indonesian Ministry of Health and became the only manufacturer of dialyzers in Taiwan that has obtained the Indonesian license. It also set a new milestone for BenQ's overseas market arrangement.
BenQ Group has been actively deploying the ASEAN medical market in recent years, and has faith in the growth potential of Indonesia, and led the group's BenQ Dialysis Technology, BenQ Dental, and Lily Medical to go to Jakarta, Indonesia from October 23 to October 26 to participate in the 31st INDONESIAN HOSPITAL EXPO.
BenQ Group sees Thailand as the hub of medical equipment in the ASEAN region, and is also a region with high medical expenditure in ASEAN countries. BenQ Medical (stock code: 4116) and K2 International will participate in the "2019 MDA Thailand and ASEAN Medical Equipment Exhibition" in Bangkok, Thailand from July 10th to July 12th, actively expanding the Thailand and ASEAN markets.
On the Jan 23rd, K2 International, invested by the group, officially established a branch in Thailand, becoming K2’s first stronghold in Southeast Asia. It will provide dialysis, medical beauty and other related products and services in Thailand, which will be replicated this experience to other Southeast Asian countries in the future.
This website uses browser records (Cookies) to provide you with the best experience. The cookies we use also include third-party cookies.